The three - day exhibition iPHEX 2013 organised by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) may yield over Rs. 1000 cr profit.
Says Dr P V Appaji, director general, Pharmexcil, “The three days exhibition has thrown up possibilities for generating approx. Rs. 1000 cr business for the exhibitors present. We have observed over 19,500 footfalls the three days (Day 1- 6000 + Day 2 - 7500 + Day 3 – 6000). We are honoured to interact with Indian and international regulators. The international regulators were happy to interact with several Indian regulators during the planned panel discussion. The panel discussion supported the exhibitors as it discussed various issues faced by each other. Indian regulators assured that all the medicine to be exported from India will be better in terms of quality.”
Touted as India’s own pharmaceutical show under the support of Ministry of Commerce & Industry, Department of Commerce, and Government of India, the event had 250 stalls of Indian pharma majors like Ranbaxy, Lupin, Glenmark, Mylan, MSN Labs, Ipca, Ind-Swift, Strides, Aurobindo, Mankind. It had over 5000 trade visitors including overseas buyer, delegates from highly regulated market like USA, Europe, Australia, New Zealand and 3000 Pharmexcil registered members. Over 500 overseas buyers were invited with the support of Ministry of Commerce and Industry Government of India. About 70 per cent of stalls were to SMEs which present a very robust, competent and competitive Indian pharma sector.
The exhibition was inaugurated by Chief Guest, Honorable Maharashtra Chief Minister Prithviraj Chavan and special guest of honour Rajeev Kher, additional secretary – Ministry of Commerce and Industry in the presence of Dr G N Singh, Drug Controller General of India (DCGI) and Mahesh Zagade, commissioner of Maharashtra Food and Drug Administration (FDA).
Over 40 senior regulatory from 20 countries like Ghana, Tanzania, Senegal, Taiwan, Vietnam, Philippine, Benin, Botswana, Burkina Faso, Egypt, Ghana, Niger, Nigeria, Seychelles, Uganda, Belaru, Haiti, Cuba, Dominic Republic, Mongolia, Srilanka, Zimbabwe, Ministry of Health officials and drug regulators chief from Maharashtra, Andhra Pradesh, Gujrat, Karnataka were present for iPHEX-2013.
The presence of large number of drug regulators from overseas market immensely helped Pharmexcil and its members to promote the quality and affordability aspect as envisaged in Brand India Pharma Campaign. The campaign was initiated by Ministry of Commerce and executed by Pharmaceuticals Export Promotion Council in association with IBEF.
“Each one was thrilled with the 10,000 sq mt three days exhibition. This exhibition gave high opportunities and supported to explore new avenues. The international exhibitors were happy with the hospitality given by Pharmexcil and assured there will be quantum leads of business for pharma industry in India,” said Bhavin Mehta, committee chief of iPHEX and CoA member, Pharmexcil.
“For the first time in the history of any exhibition, hosted and confirmed 526 oversea delegates from 104 countries from the database we have prepared before the exhibition started. The exhibition was helped with the support of Networking Software, Moozup. The exhibition scheduled over 7500 meetings in three days with the help of Moozup. The concept of buyer and sellers meet was highly appreciated by everyone. Over 70 per cent of stalls were SMEs where the buyers were excited to find new suppliers since this will reduce the cost of procurement and will also reduce health care cost,” Mehta added.